01381nas a2200433   4500000000100000000000100001000000100002008004100003653001100044653000900055653001100064653000900075653002800084653006100112653002000173653003200193653004700225653002200272653005700294653002300351653005700374653006100431653002600492653001600518653002000534653001700554653002800571100001500599700001300614700002200627700001400649700001700663700001800680700001700698245017900715250001500894490000700909020003100916       2024                            d10aHumans10aMale10aFemale10aAged10aCross-Sectional Studies10a*Cognitive Dysfunction/epidemiology/psychology/diagnosis10a*Multimorbidity10aUnited Kingdom/epidemiology10a*Frailty/epidemiology/psychology/diagnosis10aAged, 80 and over10a*Parkinson Disease/psychology/epidemiology/diagnosis10a*Patient Selection10aFrail Elderly/psychology/statistics & numerical data10aParkinsonian Disorders/epidemiology/psychology/diagnosis10aParkinson’s disease10ainclusivity10amental capacity10aOlder people10aunderserved populations1 aE. Tenison1 aM. Smith1 aD. Pendry-Brazier1 aA. Cullen1 aF. Lithander1 aY. Ben-Shlomo1 aE. Henderson00aEnhancing recruitment of individuals living with frailty, multimorbidity and cognitive impairment to Parkinson's research: experiences from the PRIME-UK cross-sectional study  a2024/05/240 v53  a0002-0729 (Print)0002-0729